See if your patients are eligible for the WATCHMAN Implant
Take a 4-in-1 eligibility screener and risk score calculator to see if your atrial fibrillation patient may be eligible for the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Implant.
Your referral can make a difference.
Protection against stroke risk. Protection against oral anticoagulant (OAC) bleed risk. The WATCHMAN Implant is the one-time, minimally invasive procedure that protects your atrial fibrillation (AFib) patients for life.
Learn about the WATCHMAN Implant
Explore information about the WATCHMAN LAAC Implant for stroke risk reduction in patients with non-valvular atrial fibrillation. Access educational resources, videos and more.
Most searched topics:
Proven*
10 years
FDA approved
20+
Years of clinical experience
Safe1
99%
Implant success rate†
0.5%
Major adverse event rate**
Effective1
96.2%
Of patients discontinued OACs at 45 days
Have a question or need support?
Have a Boston Scientific representative contact you regarding WATCHMAN
* Represents all WATCHMAN models.
† Procedure success defined as successful delivery and release of a WATCHMAN FLX Device into the LAA.
** Occurrence of one of the following events between the time of implant and within 7 days following the procedure or by hospital discharge, whichever is later: all-cause death, ischemic stroke, systemic embolism, or device or procedure related events requiring open cardiac surgery or major endovascular intervention.
References
- Kar, S., et al, Primary Outcome Evaluation of the Next Generation LAAC Device: Results from the PINNACLE FLX Trial, Circulation, 2021.
SH-2333106-AA